Numedii
Latest round
- Series A
Last raised
- May 2015
Total raised
- $5.5M
Investors
- 6
About Numedii
Founded in 2008 and headquartered in Menlo Park, US, Numedii focuses on accelerating drug discovery through its proprietary analytics platform.Numedii specializes in advanced data-driven solutions aimed at accelerating drug discovery and development processes. Their core product offerings include a proprietary platform that integrates artificial intelligence with deep learning methodologies to analyze vast biological datasets. This innovative technology is designed to identify novel drug candidates and optimize existing therapies, addressing critical challenges in the pharmaceutical and biotechnology sectors. Numedii targets a diverse client base, which includes pharmaceutical companies, research institutions, and healthcare providers primarily in North America and Europe.Numedii's revenue model is structured around B2B transactions, primarily involving subscription-based services and licensing agreements with pharmaceutical and biotech companies. Clients engage with Numedii through tailored partnerships that grant access to their advanced analytics platform, enhancing drug development processes. Financial transactions typically involve multi-year contracts, which include initial setup fees followed by recurring subscription charges corresponding to the level of service and data access provided. The company is currently in the process of designing new features for its analytics platform, which are expected to launch by late 2023. Additionally, Numedii aims to penetrate new markets in Asia and South America by 2024, specifically targeting pharmaceutical firms and research institutions in those regions.
Who invested in Numedii
6 investors across 2 rounds
See all investors in Numedii
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Numedii
Who invested in Numedii?
Numedii has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Numedii raised?
Numedii has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Numedii last raise money?
Numedii's most recent round on record is a Series A, in May 2015.
What does Numedii do?
Founded in 2008 and headquartered in Menlo Park, US, Numedii focuses on accelerating drug discovery through its proprietary analytics platform.
Where is Numedii headquartered?
Numedii is headquartered in Menlo Park, US.
Which VCs invest in companies like Numedii?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Numedii's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Numedii? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.